J Okla Dent Assoc 100:2425 Wong M, Sade S, Gilbert M, Klieb HB (2011) Oral melanosis after tyrosine kinase inhibition with imatinib for chronic myelogenous leukemia: report of a case and review of the literature
As we move forward, the importance of continuous education, research, and patient engagement in this area remains paramount to achieving optimal therapeutic outcomes
We identified one such ligand, designated P5 and have characterized its in vitro pharmacological phenotype, and explored its therapeutic potential
Thats why they work in such a targeted, sustainable way
Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia. Fertility and sterility 84.3 (2005): 662-671
Your Month-by-Month Action Plan Month 1: Start anti-nausea meds proactively